Inappropriate prescribing in patients with kidney disease: A rapid review of prevalence, associated clinical outcomes and impact of interventions.
Zohra HamzaeiMorten Baltzer HoulindLene Juel KjeldsenLouise Westberg Strejby ChristensenAnne Byriel WallsAnissa AharazCharlotte OlesenFaruk CoricJoo Hanne Poulsen RevellLene Vestergaard Ravn-NielsenTrine Rune Høgh AndersenUlla HedegaardPublished in: Basic & clinical pharmacology & toxicology (2024)
This review highlights widespread IP in CKD patients across healthcare settings, with varying prevalence rates. IP is substantially linked to adverse outcomes in patients. While limited interventions show promise, urgent research is needed to develop effective strategies addressing IP and improving CKD patient care.